vs
Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $173.1M, roughly 1.1× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 0.9%, a 19.4% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -18.0%).
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
CASH vs FOLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $173.1M | $185.2M |
| Net Profit | $35.2M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 24.6% | 8.6% |
| Net Margin | 20.3% | 0.9% |
| Revenue YoY | -0.2% | 23.7% |
| Net Profit YoY | 11.9% | -88.5% |
| EPS (diluted) | $1.57 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $173.1M | $185.2M | ||
| Q3 25 | $186.7M | $169.1M | ||
| Q2 25 | $195.8M | $154.7M | ||
| Q1 25 | $274.8M | $125.2M | ||
| Q4 24 | $182.6M | $149.7M | ||
| Q3 24 | $179.5M | $141.5M | ||
| Q2 24 | $188.6M | $126.7M | ||
| Q1 24 | $257.6M | $110.4M |
| Q4 25 | $35.2M | $1.7M | ||
| Q3 25 | $38.8M | $17.3M | ||
| Q2 25 | $42.1M | $-24.4M | ||
| Q1 25 | $75.0M | $-21.7M | ||
| Q4 24 | $30.0M | $14.7M | ||
| Q3 24 | $33.5M | $-6.7M | ||
| Q2 24 | $44.9M | $-15.7M | ||
| Q1 24 | $69.9M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 24.6% | 8.6% | ||
| Q3 25 | 25.9% | 20.3% | ||
| Q2 25 | 24.1% | -6.1% | ||
| Q1 25 | 33.2% | -6.3% | ||
| Q4 24 | 19.8% | 10.7% | ||
| Q3 24 | 20.9% | 15.3% | ||
| Q2 24 | 27.1% | 11.8% | ||
| Q1 24 | 33.8% | -25.1% |
| Q4 25 | 20.3% | 0.9% | ||
| Q3 25 | 20.8% | 10.2% | ||
| Q2 25 | 21.5% | -15.8% | ||
| Q1 25 | 27.3% | -17.3% | ||
| Q4 24 | 16.4% | 9.8% | ||
| Q3 24 | 18.7% | -4.8% | ||
| Q2 24 | 23.8% | -12.4% | ||
| Q1 24 | 27.1% | -43.9% |
| Q4 25 | $1.57 | $0.00 | ||
| Q3 25 | $1.69 | $0.06 | ||
| Q2 25 | $1.81 | $-0.08 | ||
| Q1 25 | $3.14 | $-0.07 | ||
| Q4 24 | $1.23 | $0.05 | ||
| Q3 24 | $1.34 | $-0.02 | ||
| Q2 24 | $1.78 | $-0.05 | ||
| Q1 24 | $2.74 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $331.2M | $293.5M |
| Total DebtLower is stronger | $33.5M | $392.7M |
| Stockholders' EquityBook value | $854.5M | $274.2M |
| Total Assets | $7.6B | $949.9M |
| Debt / EquityLower = less leverage | 0.04× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $331.2M | $293.5M | ||
| Q3 25 | $120.6M | $263.8M | ||
| Q2 25 | $258.3M | $231.0M | ||
| Q1 25 | $254.2M | $250.6M | ||
| Q4 24 | $597.4M | $249.9M | ||
| Q3 24 | $158.3M | $249.8M | ||
| Q2 24 | $298.9M | $260.1M | ||
| Q1 24 | $347.9M | $239.6M |
| Q4 25 | $33.5M | $392.7M | ||
| Q3 25 | $33.5M | $392.0M | ||
| Q2 25 | $33.4M | $391.3M | ||
| Q1 25 | $33.4M | $390.7M | ||
| Q4 24 | $33.4M | $390.1M | ||
| Q3 24 | $33.4M | $389.5M | ||
| Q2 24 | $33.3M | $388.9M | ||
| Q1 24 | $33.4M | $388.4M |
| Q4 25 | $854.5M | $274.2M | ||
| Q3 25 | $858.0M | $230.4M | ||
| Q2 25 | $819.0M | $204.3M | ||
| Q1 25 | $814.7M | $193.6M | ||
| Q4 24 | $758.3M | $194.0M | ||
| Q3 24 | $822.5M | $178.8M | ||
| Q2 24 | $748.4M | $132.5M | ||
| Q1 24 | $719.5M | $130.7M |
| Q4 25 | $7.6B | $949.9M | ||
| Q3 25 | $7.2B | $868.8M | ||
| Q2 25 | $7.2B | $815.3M | ||
| Q1 25 | $7.0B | $789.8M | ||
| Q4 24 | $7.6B | $785.0M | ||
| Q3 24 | $7.5B | $786.6M | ||
| Q2 24 | $7.5B | $749.5M | ||
| Q1 24 | $7.4B | $721.8M |
| Q4 25 | 0.04× | 1.43× | ||
| Q3 25 | 0.04× | 1.70× | ||
| Q2 25 | 0.04× | 1.92× | ||
| Q1 25 | 0.04× | 2.02× | ||
| Q4 24 | 0.04× | 2.01× | ||
| Q3 24 | 0.04× | 2.18× | ||
| Q2 24 | 0.04× | 2.93× | ||
| Q1 24 | 0.05× | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.3M | $16.3M |
| Free Cash FlowOCF − Capex | $104.1M | $16.0M |
| FCF MarginFCF / Revenue | 60.1% | 8.6% |
| Capex IntensityCapex / Revenue | 2.4% | 0.2% |
| Cash ConversionOCF / Net Profit | 3.08× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $616.8M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.3M | $16.3M | ||
| Q3 25 | $303.7M | $35.7M | ||
| Q2 25 | $30.4M | $-26.5M | ||
| Q1 25 | $188.3M | $7.8M | ||
| Q4 24 | $-71.7M | $-3.9M | ||
| Q3 24 | $143.1M | $-23.0M | ||
| Q2 24 | $113.2M | $22.7M | ||
| Q1 24 | $203.0M | $-29.7M |
| Q4 25 | $104.1M | $16.0M | ||
| Q3 25 | $300.3M | $35.3M | ||
| Q2 25 | $27.7M | $-28.9M | ||
| Q1 25 | $184.7M | $7.5M | ||
| Q4 24 | $-73.8M | $-4.2M | ||
| Q3 24 | $138.8M | $-23.3M | ||
| Q2 24 | $111.0M | $21.6M | ||
| Q1 24 | $201.3M | $-31.5M |
| Q4 25 | 60.1% | 8.6% | ||
| Q3 25 | 160.9% | 20.9% | ||
| Q2 25 | 14.1% | -18.7% | ||
| Q1 25 | 67.2% | 6.0% | ||
| Q4 24 | -40.4% | -2.8% | ||
| Q3 24 | 77.3% | -16.5% | ||
| Q2 24 | 58.8% | 17.0% | ||
| Q1 24 | 78.1% | -28.5% |
| Q4 25 | 2.4% | 0.2% | ||
| Q3 25 | 1.8% | 0.2% | ||
| Q2 25 | 1.4% | 1.6% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 1.1% | 0.2% | ||
| Q3 24 | 2.4% | 0.3% | ||
| Q2 24 | 1.2% | 0.9% | ||
| Q1 24 | 0.7% | 1.6% |
| Q4 25 | 3.08× | 9.62× | ||
| Q3 25 | 7.83× | 2.06× | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 2.51× | — | ||
| Q4 24 | -2.39× | -0.27× | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 2.52× | — | ||
| Q1 24 | 2.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
